VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: VLAD who wrote (21449)	4/27/1999 5:15:00 PM
From: Maverick & Goose	Read Replies (1) of 23519

There is an article in the New York Times "Science/Health" section today regarding Viagra's introduction in Japan. I tried several times to attach the link, but keep running into a problem (sorry). If anyone wants to read it, it's at "www.nyt.com" under the Science and Health heading. Not sure what everyone's opinion will be, but I think this will be very good for Vivus in the long run. This is based on the side effects of Viagra becoming more widely covered in the media. Sort of a back door approach; let Viagra define the ED market and let Vivus sell the safe alternative. Maverick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next